secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001753926-23-001389
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella raises $2M via private placement of pre-funded warrants and warrants
----------------------------------------------------------------------------

- Gross proceeds ~$2M from sale of 1,315,790 pre-funded warrants (exercise $0.001) and 1,315,790 warrants (exercise $1.40) at $1.519/unit.
- Warrants immediately exercisable, expire in 3 years; exercise price $1.40 per share.
- H.C. Wainwright acted as exclusive placement agent; received 7.5% cash fee, 1% mgmt fee, $50k expense allowance, and 98,684 placement agent warrants.
- Company agreed to file resale registration statement within 7 business days, effective within 45-75 calendar days.
- Net proceeds intended for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001389/0001753926-23-001389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001389/g083821_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer